Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FXGZH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count units). This firm fixed-price delivery order, issued on August 7, 2025, with completion targeted for August 28, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026. The IDC, established under the SPE2DB program, authorizes the agency to issue delivery orders for a comprehensive portfolio of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group, registered in the System for Award Management since 2001, specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. The company has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards demonstrating consistent capability in delivering specialized pharmaceutical products ranging from oncology treatments to contraceptive devices and auto-injectors. This delivery order was awarded without a set-aside designation, reflecting the contractor's competitive positioning in the open federal procurement market while leveraging its small business status.
Quick answers
Who was awarded contract SPE2DB25FXGZH?
SPE2DB25FXGZH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FXGZH worth?
The government has obligated $3,459 on SPE2DB25FXGZH.
Is contract SPE2DB25FXGZH an order under another contract?
Yes. SPE2DB25FXGZH is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB25FXGZH competed?
The extent of competition for SPE2DB25FXGZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award